カテゴリー： 世界, 医療/バイオ, LP Information

世界の関節痛治療市場予測 2023年-2029年

【英語タイトル】Global Arthralgia Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00657）・商品コード：LP23DC00657
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の関節痛治療市場」は、過去の販売実績から2022年の世界の関節痛治療の総販売量を検討し、2023年から2029年の予測される関節痛治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の関節痛治療の市場規模を掲載し、XXX百万米ドル規模の世界の関節痛治療市場の詳細な分析を提供します。本インサイトレポートは、世界の関節痛治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の関節痛治療市場における各社の独自のポジションをより深く理解するために、関節痛治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の関節痛治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。関節痛治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。関節痛治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。関節痛治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

関節痛治療の世界主要メーカーとしては、Pfizer Inc.、 GSK Plc、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi S.A、 Boehringer Ingelheim International GmbH、 AstraZeneca、 Johnson & Johnson Private Limited、 Merck & Co., Inc.、 Hoffmann-La Roche Ltd.、 Bristol-Myers Squibb Companyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の関節痛治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では関節痛治療市場をセグメンテーションし、種類別 (非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の関節痛治療市場の10年間の市場状況・展望は？
・世界および地域別に見た関節痛治療市場成長の要因は何か？
・関節痛治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・関節痛治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：関節痛治療の年間販売量2018-2029、地域別現状・将来分析
・関節痛治療の種類別セグメント：非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質
・関節痛治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・関節痛治療の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・関節痛治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の関節痛治療市場
・企業別のグローバル関節痛治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の関節痛治療の年間売上：2018-2023年の売上、市場シェア
・企業別の関節痛治療販売価格
・主要企業の関節痛治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

関節痛治療の地域別レビュー
・地域別の関節痛治療市場規模2018-2023：年間販売量、売上
・主要国別の関節痛治療市場規模2018-2023：年間販売量、売上
・南北アメリカの関節痛治療販売の成長
・アジア太平洋の関節痛治療販売の成長
・ヨーロッパの関節痛治療販売の成長
・中東・アフリカの関節痛治療販売の成長

南北アメリカ市場
・南北アメリカの国別の関節痛治療販売量、売上（2018-2023）
・南北アメリカの関節痛治療の種類別販売量
・南北アメリカの関節痛治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の関節痛治療販売量、売上（2018-2023）
・アジア太平洋の関節痛治療の種類別販売量
・アジア太平洋の関節痛治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の関節痛治療販売量、売上（2018-2023）
・ヨーロッパの関節痛治療の種類別販売量
・ヨーロッパの関節痛治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の関節痛治療販売量、売上（2018-2023）
・中東・アフリカの関節痛治療の種類別販売量
・中東・アフリカの関節痛治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・関節痛治療の製造コスト構造分析
・関節痛治療の製造プロセス分析
・関節痛治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・関節痛治療の主要なグローバル販売業者
・関節痛治療の主要なグローバル顧客

地域別の関節痛治療市場予測レビュー
・地域別の関節痛治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・関節痛治療の種類別市場規模予測
・関節痛治療の用途別市場規模予測

主要企業分析
Pfizer Inc.、 GSK Plc、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi S.A、 Boehringer Ingelheim International GmbH、 AstraZeneca、 Johnson & Johnson Private Limited、 Merck & Co., Inc.、 Hoffmann-La Roche Ltd.、 Bristol-Myers Squibb Company
・企業情報
・関節痛治療製品
・関節痛治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Arthralgia Treatment market size is projected to grow from US$ 5820.6 million in 2022 to US$ 10940 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.
United States market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Arthralgia Treatment players cover Pfizer Inc., GSK Plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi S.A, Boehringer Ingelheim International GmbH, AstraZeneca and Johnson & Johnson Private Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Arthralgia describes joint stiffness. Among its many causes are overuse, sprains, injury, gout, tendonitis and a number of infectious diseases, including rheumatic fever and chickenpox. Many people are becoming more aware of the importance of joint health and are taking proactive steps to manage joint pain. This includes regular exercise, a healthy diet, and the use of arthralgia management products such as supplements, pain relievers, and topical creams.
LPI (LP Information)’ newest research report, the “Arthralgia Treatment Industry Forecast” looks at past sales and reviews total world Arthralgia Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Arthralgia Treatment sales for 2023 through 2029. With Arthralgia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Arthralgia Treatment industry.
This Insight Report provides a comprehensive analysis of the global Arthralgia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Arthralgia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Arthralgia Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Arthralgia Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Arthralgia Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Arthralgia Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
NSAID
Corticosteroids
Antidepressants
Anticonvulsants
Antibiotics
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer Inc.
GSK Plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Merck & Co., Inc.
Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Arthralgia Treatment market?
What factors are driving Arthralgia Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Arthralgia Treatment market opportunities vary by end market size?
How does Arthralgia Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Arthralgia Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Arthralgia Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Arthralgia Treatment by Country/Region, 2018, 2022 & 2029
2.2 Arthralgia Treatment Segment by Type
2.2.1 NSAID
2.2.2 Corticosteroids
2.2.3 Antidepressants
2.2.4 Anticonvulsants
2.2.5 Antibiotics
2.3 Arthralgia Treatment Sales by Type
2.3.1 Global Arthralgia Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Arthralgia Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Arthralgia Treatment Sale Price by Type (2018-2023)
2.4 Arthralgia Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Arthralgia Treatment Sales by Application
2.5.1 Global Arthralgia Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Arthralgia Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Arthralgia Treatment Sale Price by Application (2018-2023)
3 Global Arthralgia Treatment by Company
3.1 Global Arthralgia Treatment Breakdown Data by Company
3.1.1 Global Arthralgia Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Arthralgia Treatment Sales Market Share by Company (2018-2023)
3.2 Global Arthralgia Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Arthralgia Treatment Revenue by Company (2018-2023)
3.2.2 Global Arthralgia Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Arthralgia Treatment Sale Price by Company
3.4 Key Manufacturers Arthralgia Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Arthralgia Treatment Product Location Distribution
3.4.2 Players Arthralgia Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Arthralgia Treatment by Geographic Region
4.1 World Historic Arthralgia Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Arthralgia Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Arthralgia Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Arthralgia Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Arthralgia Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Arthralgia Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Arthralgia Treatment Sales Growth
4.4 APAC Arthralgia Treatment Sales Growth
4.5 Europe Arthralgia Treatment Sales Growth
4.6 Middle East & Africa Arthralgia Treatment Sales Growth
5 Americas
5.1 Americas Arthralgia Treatment Sales by Country
5.1.1 Americas Arthralgia Treatment Sales by Country (2018-2023)
5.1.2 Americas Arthralgia Treatment Revenue by Country (2018-2023)
5.2 Americas Arthralgia Treatment Sales by Type
5.3 Americas Arthralgia Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Arthralgia Treatment Sales by Region
6.1.1 APAC Arthralgia Treatment Sales by Region (2018-2023)
6.1.2 APAC Arthralgia Treatment Revenue by Region (2018-2023)
6.2 APAC Arthralgia Treatment Sales by Type
6.3 APAC Arthralgia Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Arthralgia Treatment by Country
7.1.1 Europe Arthralgia Treatment Sales by Country (2018-2023)
7.1.2 Europe Arthralgia Treatment Revenue by Country (2018-2023)
7.2 Europe Arthralgia Treatment Sales by Type
7.3 Europe Arthralgia Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Arthralgia Treatment by Country
8.1.1 Middle East & Africa Arthralgia Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Arthralgia Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Arthralgia Treatment Sales by Type
8.3 Middle East & Africa Arthralgia Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Arthralgia Treatment
10.3 Manufacturing Process Analysis of Arthralgia Treatment
10.4 Industry Chain Structure of Arthralgia Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Arthralgia Treatment Distributors
11.3 Arthralgia Treatment Customer
12 World Forecast Review for Arthralgia Treatment by Geographic Region
12.1 Global Arthralgia Treatment Market Size Forecast by Region
12.1.1 Global Arthralgia Treatment Forecast by Region (2024-2029)
12.1.2 Global Arthralgia Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Arthralgia Treatment Forecast by Type
12.7 Global Arthralgia Treatment Forecast by Application
13 Key Players Analysis
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Arthralgia Treatment Product Portfolios and Specifications
13.1.3 Pfizer Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 GSK Plc
13.2.1 GSK Plc Company Information
13.2.2 GSK Plc Arthralgia Treatment Product Portfolios and Specifications
13.2.3 GSK Plc Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Plc Main Business Overview
13.2.5 GSK Plc Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Arthralgia Treatment Product Portfolios and Specifications
13.3.3 Novartis AG Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Mylan N.V.
13.4.1 Mylan N.V. Company Information
13.4.2 Mylan N.V. Arthralgia Treatment Product Portfolios and Specifications
13.4.3 Mylan N.V. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan N.V. Main Business Overview
13.4.5 Mylan N.V. Latest Developments
13.5 Teva Pharmaceutical Industries Ltd.
13.5.1 Teva Pharmaceutical Industries Ltd. Company Information
13.5.2 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A Company Information
13.6.2 Sanofi S.A Arthralgia Treatment Product Portfolios and Specifications
13.6.3 Sanofi S.A Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi S.A Main Business Overview
13.6.5 Sanofi S.A Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH Arthralgia Treatment Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Arthralgia Treatment Product Portfolios and Specifications
13.8.3 AstraZeneca Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Johnson & Johnson Private Limited
13.9.1 Johnson & Johnson Private Limited Company Information
13.9.2 Johnson & Johnson Private Limited Arthralgia Treatment Product Portfolios and Specifications
13.9.3 Johnson & Johnson Private Limited Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Johnson & Johnson Private Limited Main Business Overview
13.9.5 Johnson & Johnson Private Limited Latest Developments
13.10 Merck & Co., Inc.
13.10.1 Merck & Co., Inc. Company Information
13.10.2 Merck & Co., Inc. Arthralgia Treatment Product Portfolios and Specifications
13.10.3 Merck & Co., Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co., Inc. Main Business Overview
13.10.5 Merck & Co., Inc. Latest Developments
13.11 Hoffmann-La Roche Ltd.
13.11.1 Hoffmann-La Roche Ltd. Company Information
13.11.2 Hoffmann-La Roche Ltd. Arthralgia Treatment Product Portfolios and Specifications
13.11.3 Hoffmann-La Roche Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hoffmann-La Roche Ltd. Main Business Overview
13.11.5 Hoffmann-La Roche Ltd. Latest Developments
13.12 Bristol-Myers Squibb Company
13.12.1 Bristol-Myers Squibb Company Company Information
13.12.2 Bristol-Myers Squibb Company Arthralgia Treatment Product Portfolios and Specifications
13.12.3 Bristol-Myers Squibb Company Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bristol-Myers Squibb Company Main Business Overview
13.12.5 Bristol-Myers Squibb Company Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Arthralgia Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Arthralgia Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NSAID
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Antidepressants
Table 6. Major Players of Anticonvulsants
Table 7. Major Players of Antibiotics
Table 8. Global Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 9. Global Arthralgia Treatment Sales Market Share by Type (2018-2023)
Table 10. Global Arthralgia Treatment Revenue by Type (2018-2023) & ($ million)
Table 11. Global Arthralgia Treatment Revenue Market Share by Type (2018-2023)
Table 12. Global Arthralgia Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 14. Global Arthralgia Treatment Sales Market Share by Application (2018-2023)
Table 15. Global Arthralgia Treatment Revenue by Application (2018-2023)
Table 16. Global Arthralgia Treatment Revenue Market Share by Application (2018-2023)
Table 17. Global Arthralgia Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Arthralgia Treatment Sales by Company (2018-2023) & (K Units)
Table 19. Global Arthralgia Treatment Sales Market Share by Company (2018-2023)
Table 20. Global Arthralgia Treatment Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Arthralgia Treatment Revenue Market Share by Company (2018-2023)
Table 22. Global Arthralgia Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Arthralgia Treatment Producing Area Distribution and Sales Area
Table 24. Players Arthralgia Treatment Products Offered
Table 25. Arthralgia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Arthralgia Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Arthralgia Treatment Sales Market Share Geographic Region (2018-2023)
Table 30. Global Arthralgia Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Arthralgia Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Arthralgia Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Arthralgia Treatment Sales Market Share by Country/Region (2018-2023)
Table 34. Global Arthralgia Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Arthralgia Treatment Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 37. Americas Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 38. Americas Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 40. Americas Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 41. Americas Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 42. APAC Arthralgia Treatment Sales by Region (2018-2023) & (K Units)
Table 43. APAC Arthralgia Treatment Sales Market Share by Region (2018-2023)
Table 44. APAC Arthralgia Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Arthralgia Treatment Revenue Market Share by Region (2018-2023)
Table 46. APAC Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 47. APAC Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 48. Europe Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 49. Europe Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 50. Europe Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 52. Europe Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 53. Europe Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Arthralgia Treatment
Table 61. Key Market Challenges & Risks of Arthralgia Treatment
Table 62. Key Industry Trends of Arthralgia Treatment
Table 63. Arthralgia Treatment Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Arthralgia Treatment Distributors List
Table 66. Arthralgia Treatment Customer List
Table 67. Global Arthralgia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Arthralgia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Arthralgia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Arthralgia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Arthralgia Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Arthralgia Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Arthralgia Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Arthralgia Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Inc. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Inc. Arthralgia Treatment Product Portfolios and Specifications
Table 83. Pfizer Inc. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Inc. Main Business
Table 85. Pfizer Inc. Latest Developments
Table 86. GSK Plc Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 87. GSK Plc Arthralgia Treatment Product Portfolios and Specifications
Table 88. GSK Plc Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. GSK Plc Main Business
Table 90. GSK Plc Latest Developments
Table 91. Novartis AG Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis AG Arthralgia Treatment Product Portfolios and Specifications
Table 93. Novartis AG Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Novartis AG Main Business
Table 95. Novartis AG Latest Developments
Table 96. Mylan N.V. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan N.V. Arthralgia Treatment Product Portfolios and Specifications
Table 98. Mylan N.V. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Mylan N.V. Main Business
Table 100. Mylan N.V. Latest Developments
Table 101. Teva Pharmaceutical Industries Ltd. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product Portfolios and Specifications
Table 103. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Teva Pharmaceutical Industries Ltd. Main Business
Table 105. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 106. Sanofi S.A Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi S.A Arthralgia Treatment Product Portfolios and Specifications
Table 108. Sanofi S.A Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Sanofi S.A Main Business
Table 110. Sanofi S.A Latest Developments
Table 111. Boehringer Ingelheim International GmbH Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 112. Boehringer Ingelheim International GmbH Arthralgia Treatment Product Portfolios and Specifications
Table 113. Boehringer Ingelheim International GmbH Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Boehringer Ingelheim International GmbH Main Business
Table 115. Boehringer Ingelheim International GmbH Latest Developments
Table 116. AstraZeneca Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Arthralgia Treatment Product Portfolios and Specifications
Table 118. AstraZeneca Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Johnson & Johnson Private Limited Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 122. Johnson & Johnson Private Limited Arthralgia Treatment Product Portfolios and Specifications
Table 123. Johnson & Johnson Private Limited Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Johnson & Johnson Private Limited Main Business
Table 125. Johnson & Johnson Private Limited Latest Developments
Table 126. Merck & Co., Inc. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck & Co., Inc. Arthralgia Treatment Product Portfolios and Specifications
Table 128. Merck & Co., Inc. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Merck & Co., Inc. Main Business
Table 130. Merck & Co., Inc. Latest Developments
Table 131. Hoffmann-La Roche Ltd. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 132. Hoffmann-La Roche Ltd. Arthralgia Treatment Product Portfolios and Specifications
Table 133. Hoffmann-La Roche Ltd. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Hoffmann-La Roche Ltd. Main Business
Table 135. Hoffmann-La Roche Ltd. Latest Developments
Table 136. Bristol-Myers Squibb Company Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 137. Bristol-Myers Squibb Company Arthralgia Treatment Product Portfolios and Specifications
Table 138. Bristol-Myers Squibb Company Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Bristol-Myers Squibb Company Main Business
Table 140. Bristol-Myers Squibb Company Latest Developments
List of Figures
Figure 1. Picture of Arthralgia Treatment
Figure 2. Arthralgia Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Arthralgia Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Arthralgia Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Arthralgia Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NSAID
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Antidepressants
Figure 12. Product Picture of Anticonvulsants
Figure 13. Product Picture of Antibiotics
Figure 14. Global Arthralgia Treatment Sales Market Share by Type in 2022
Figure 15. Global Arthralgia Treatment Revenue Market Share by Type (2018-2023)
Figure 16. Arthralgia Treatment Consumed in Hospital Pharmacy
Figure 17. Global Arthralgia Treatment Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 18. Arthralgia Treatment Consumed in Retail Pharmacy
Figure 19. Global Arthralgia Treatment Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 20. Arthralgia Treatment Consumed in Online Pharmacy
Figure 21. Global Arthralgia Treatment Market: Online Pharmacy (2018-2023) & (K Units)
Figure 22. Global Arthralgia Treatment Sales Market Share by Application (2022)
Figure 23. Global Arthralgia Treatment Revenue Market Share by Application in 2022
Figure 24. Arthralgia Treatment Sales Market by Company in 2022 (K Units)
Figure 25. Global Arthralgia Treatment Sales Market Share by Company in 2022
Figure 26. Arthralgia Treatment Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Arthralgia Treatment Revenue Market Share by Company in 2022
Figure 28. Global Arthralgia Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Arthralgia Treatment Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 31. Americas Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 32. APAC Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 33. APAC Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Europe Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 35. Europe Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 38. Americas Arthralgia Treatment Sales Market Share by Country in 2022
Figure 39. Americas Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 40. Americas Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 41. Americas Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 42. United States Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Arthralgia Treatment Sales Market Share by Region in 2022
Figure 47. APAC Arthralgia Treatment Revenue Market Share by Regions in 2022
Figure 48. APAC Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 49. APAC Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 50. China Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Arthralgia Treatment Sales Market Share by Country in 2022
Figure 58. Europe Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 59. Europe Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 60. Europe Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 61. Germany Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Arthralgia Treatment Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 70. Egypt Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Arthralgia Treatment in 2022
Figure 76. Manufacturing Process Analysis of Arthralgia Treatment
Figure 77. Industry Chain Structure of Arthralgia Treatment
Figure 78. Channels of Distribution
Figure 79. Global Arthralgia Treatment Sales Market Forecast by Region (2024-2029)
Figure 80. Global Arthralgia Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Arthralgia Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Arthralgia Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Arthralgia Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Arthralgia Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の関節痛治療市場予測 2023年-2029年] (コード：LP23DC00657)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の関節痛治療市場予測 2023年-2029年]についてメールでお問い合わせ
カテゴリー： 世界, 医療/バイオ, LP Information

世界の関節痛治療市場予測 2023年-2029年

【英語タイトル】Global Arthralgia Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00657）・商品コード：LP23DC00657
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の関節痛治療市場」は、過去の販売実績から2022年の世界の関節痛治療の総販売量を検討し、2023年から2029年の予測される関節痛治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の関節痛治療の市場規模を掲載し、XXX百万米ドル規模の世界の関節痛治療市場の詳細な分析を提供します。本インサイトレポートは、世界の関節痛治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の関節痛治療市場における各社の独自のポジションをより深く理解するために、関節痛治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の関節痛治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。関節痛治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。関節痛治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。関節痛治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

関節痛治療の世界主要メーカーとしては、Pfizer Inc.、 GSK Plc、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi S.A、 Boehringer Ingelheim International GmbH、 AstraZeneca、 Johnson & Johnson Private Limited、 Merck & Co., Inc.、 Hoffmann-La Roche Ltd.、 Bristol-Myers Squibb Companyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の関節痛治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では関節痛治療市場をセグメンテーションし、種類別 (非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の関節痛治療市場の10年間の市場状況・展望は？
・世界および地域別に見た関節痛治療市場成長の要因は何か？
・関節痛治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・関節痛治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：関節痛治療の年間販売量2018-2029、地域別現状・将来分析
・関節痛治療の種類別セグメント：非ステロイド性抗炎症薬、副腎皮質ステロイド薬、抗うつ薬、抗けいれん薬、抗生物質
・関節痛治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・関節痛治療の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・関節痛治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の関節痛治療市場
・企業別のグローバル関節痛治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の関節痛治療の年間売上：2018-2023年の売上、市場シェア
・企業別の関節痛治療販売価格
・主要企業の関節痛治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

関節痛治療の地域別レビュー
・地域別の関節痛治療市場規模2018-2023：年間販売量、売上
・主要国別の関節痛治療市場規模2018-2023：年間販売量、売上
・南北アメリカの関節痛治療販売の成長
・アジア太平洋の関節痛治療販売の成長
・ヨーロッパの関節痛治療販売の成長
・中東・アフリカの関節痛治療販売の成長

南北アメリカ市場
・南北アメリカの国別の関節痛治療販売量、売上（2018-2023）
・南北アメリカの関節痛治療の種類別販売量
・南北アメリカの関節痛治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の関節痛治療販売量、売上（2018-2023）
・アジア太平洋の関節痛治療の種類別販売量
・アジア太平洋の関節痛治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の関節痛治療販売量、売上（2018-2023）
・ヨーロッパの関節痛治療の種類別販売量
・ヨーロッパの関節痛治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の関節痛治療販売量、売上（2018-2023）
・中東・アフリカの関節痛治療の種類別販売量
・中東・アフリカの関節痛治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・関節痛治療の製造コスト構造分析
・関節痛治療の製造プロセス分析
・関節痛治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・関節痛治療の主要なグローバル販売業者
・関節痛治療の主要なグローバル顧客

地域別の関節痛治療市場予測レビュー
・地域別の関節痛治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・関節痛治療の種類別市場規模予測
・関節痛治療の用途別市場規模予測

主要企業分析
Pfizer Inc.、 GSK Plc、 Novartis AG、 Mylan N.V.、 Teva Pharmaceutical Industries Ltd.、 Sanofi S.A、 Boehringer Ingelheim International GmbH、 AstraZeneca、 Johnson & Johnson Private Limited、 Merck & Co., Inc.、 Hoffmann-La Roche Ltd.、 Bristol-Myers Squibb Company
・企業情報
・関節痛治療製品
・関節痛治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Arthralgia Treatment market size is projected to grow from US$ 5820.6 million in 2022 to US$ 10940 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.
United States market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Arthralgia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Arthralgia Treatment players cover Pfizer Inc., GSK Plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi S.A, Boehringer Ingelheim International GmbH, AstraZeneca and Johnson & Johnson Private Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Arthralgia describes joint stiffness. Among its many causes are overuse, sprains, injury, gout, tendonitis and a number of infectious diseases, including rheumatic fever and chickenpox. Many people are becoming more aware of the importance of joint health and are taking proactive steps to manage joint pain. This includes regular exercise, a healthy diet, and the use of arthralgia management products such as supplements, pain relievers, and topical creams.
LPI (LP Information)’ newest research report, the “Arthralgia Treatment Industry Forecast” looks at past sales and reviews total world Arthralgia Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Arthralgia Treatment sales for 2023 through 2029. With Arthralgia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Arthralgia Treatment industry.
This Insight Report provides a comprehensive analysis of the global Arthralgia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Arthralgia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Arthralgia Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Arthralgia Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Arthralgia Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Arthralgia Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
NSAID
Corticosteroids
Antidepressants
Anticonvulsants
Antibiotics
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer Inc.
GSK Plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Merck & Co., Inc.
Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Key Questions Addressed in this Report
What is the 10-year outlook for the global Arthralgia Treatment market?
What factors are driving Arthralgia Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Arthralgia Treatment market opportunities vary by end market size?
How does Arthralgia Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Arthralgia Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Arthralgia Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Arthralgia Treatment by Country/Region, 2018, 2022 & 2029
2.2 Arthralgia Treatment Segment by Type
2.2.1 NSAID
2.2.2 Corticosteroids
2.2.3 Antidepressants
2.2.4 Anticonvulsants
2.2.5 Antibiotics
2.3 Arthralgia Treatment Sales by Type
2.3.1 Global Arthralgia Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Arthralgia Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Arthralgia Treatment Sale Price by Type (2018-2023)
2.4 Arthralgia Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Arthralgia Treatment Sales by Application
2.5.1 Global Arthralgia Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Arthralgia Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Arthralgia Treatment Sale Price by Application (2018-2023)
3 Global Arthralgia Treatment by Company
3.1 Global Arthralgia Treatment Breakdown Data by Company
3.1.1 Global Arthralgia Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Arthralgia Treatment Sales Market Share by Company (2018-2023)
3.2 Global Arthralgia Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Arthralgia Treatment Revenue by Company (2018-2023)
3.2.2 Global Arthralgia Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Arthralgia Treatment Sale Price by Company
3.4 Key Manufacturers Arthralgia Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Arthralgia Treatment Product Location Distribution
3.4.2 Players Arthralgia Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Arthralgia Treatment by Geographic Region
4.1 World Historic Arthralgia Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Arthralgia Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Arthralgia Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Arthralgia Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Arthralgia Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Arthralgia Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Arthralgia Treatment Sales Growth
4.4 APAC Arthralgia Treatment Sales Growth
4.5 Europe Arthralgia Treatment Sales Growth
4.6 Middle East & Africa Arthralgia Treatment Sales Growth
5 Americas
5.1 Americas Arthralgia Treatment Sales by Country
5.1.1 Americas Arthralgia Treatment Sales by Country (2018-2023)
5.1.2 Americas Arthralgia Treatment Revenue by Country (2018-2023)
5.2 Americas Arthralgia Treatment Sales by Type
5.3 Americas Arthralgia Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Arthralgia Treatment Sales by Region
6.1.1 APAC Arthralgia Treatment Sales by Region (2018-2023)
6.1.2 APAC Arthralgia Treatment Revenue by Region (2018-2023)
6.2 APAC Arthralgia Treatment Sales by Type
6.3 APAC Arthralgia Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Arthralgia Treatment by Country
7.1.1 Europe Arthralgia Treatment Sales by Country (2018-2023)
7.1.2 Europe Arthralgia Treatment Revenue by Country (2018-2023)
7.2 Europe Arthralgia Treatment Sales by Type
7.3 Europe Arthralgia Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Arthralgia Treatment by Country
8.1.1 Middle East & Africa Arthralgia Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Arthralgia Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Arthralgia Treatment Sales by Type
8.3 Middle East & Africa Arthralgia Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Arthralgia Treatment
10.3 Manufacturing Process Analysis of Arthralgia Treatment
10.4 Industry Chain Structure of Arthralgia Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Arthralgia Treatment Distributors
11.3 Arthralgia Treatment Customer
12 World Forecast Review for Arthralgia Treatment by Geographic Region
12.1 Global Arthralgia Treatment Market Size Forecast by Region
12.1.1 Global Arthralgia Treatment Forecast by Region (2024-2029)
12.1.2 Global Arthralgia Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Arthralgia Treatment Forecast by Type
12.7 Global Arthralgia Treatment Forecast by Application
13 Key Players Analysis
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Arthralgia Treatment Product Portfolios and Specifications
13.1.3 Pfizer Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 GSK Plc
13.2.1 GSK Plc Company Information
13.2.2 GSK Plc Arthralgia Treatment Product Portfolios and Specifications
13.2.3 GSK Plc Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Plc Main Business Overview
13.2.5 GSK Plc Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Arthralgia Treatment Product Portfolios and Specifications
13.3.3 Novartis AG Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Mylan N.V.
13.4.1 Mylan N.V. Company Information
13.4.2 Mylan N.V. Arthralgia Treatment Product Portfolios and Specifications
13.4.3 Mylan N.V. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan N.V. Main Business Overview
13.4.5 Mylan N.V. Latest Developments
13.5 Teva Pharmaceutical Industries Ltd.
13.5.1 Teva Pharmaceutical Industries Ltd. Company Information
13.5.2 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A Company Information
13.6.2 Sanofi S.A Arthralgia Treatment Product Portfolios and Specifications
13.6.3 Sanofi S.A Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi S.A Main Business Overview
13.6.5 Sanofi S.A Latest Developments
13.7 Boehringer Ingelheim International GmbH
13.7.1 Boehringer Ingelheim International GmbH Company Information
13.7.2 Boehringer Ingelheim International GmbH Arthralgia Treatment Product Portfolios and Specifications
13.7.3 Boehringer Ingelheim International GmbH Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boehringer Ingelheim International GmbH Main Business Overview
13.7.5 Boehringer Ingelheim International GmbH Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Arthralgia Treatment Product Portfolios and Specifications
13.8.3 AstraZeneca Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Johnson & Johnson Private Limited
13.9.1 Johnson & Johnson Private Limited Company Information
13.9.2 Johnson & Johnson Private Limited Arthralgia Treatment Product Portfolios and Specifications
13.9.3 Johnson & Johnson Private Limited Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Johnson & Johnson Private Limited Main Business Overview
13.9.5 Johnson & Johnson Private Limited Latest Developments
13.10 Merck & Co., Inc.
13.10.1 Merck & Co., Inc. Company Information
13.10.2 Merck & Co., Inc. Arthralgia Treatment Product Portfolios and Specifications
13.10.3 Merck & Co., Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co., Inc. Main Business Overview
13.10.5 Merck & Co., Inc. Latest Developments
13.11 Hoffmann-La Roche Ltd.
13.11.1 Hoffmann-La Roche Ltd. Company Information
13.11.2 Hoffmann-La Roche Ltd. Arthralgia Treatment Product Portfolios and Specifications
13.11.3 Hoffmann-La Roche Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hoffmann-La Roche Ltd. Main Business Overview
13.11.5 Hoffmann-La Roche Ltd. Latest Developments
13.12 Bristol-Myers Squibb Company
13.12.1 Bristol-Myers Squibb Company Company Information
13.12.2 Bristol-Myers Squibb Company Arthralgia Treatment Product Portfolios and Specifications
13.12.3 Bristol-Myers Squibb Company Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Bristol-Myers Squibb Company Main Business Overview
13.12.5 Bristol-Myers Squibb Company Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Arthralgia Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Arthralgia Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NSAID
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Antidepressants
Table 6. Major Players of Anticonvulsants
Table 7. Major Players of Antibiotics
Table 8. Global Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 9. Global Arthralgia Treatment Sales Market Share by Type (2018-2023)
Table 10. Global Arthralgia Treatment Revenue by Type (2018-2023) & ($ million)
Table 11. Global Arthralgia Treatment Revenue Market Share by Type (2018-2023)
Table 12. Global Arthralgia Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 14. Global Arthralgia Treatment Sales Market Share by Application (2018-2023)
Table 15. Global Arthralgia Treatment Revenue by Application (2018-2023)
Table 16. Global Arthralgia Treatment Revenue Market Share by Application (2018-2023)
Table 17. Global Arthralgia Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Arthralgia Treatment Sales by Company (2018-2023) & (K Units)
Table 19. Global Arthralgia Treatment Sales Market Share by Company (2018-2023)
Table 20. Global Arthralgia Treatment Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Arthralgia Treatment Revenue Market Share by Company (2018-2023)
Table 22. Global Arthralgia Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Arthralgia Treatment Producing Area Distribution and Sales Area
Table 24. Players Arthralgia Treatment Products Offered
Table 25. Arthralgia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Arthralgia Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Arthralgia Treatment Sales Market Share Geographic Region (2018-2023)
Table 30. Global Arthralgia Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Arthralgia Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Arthralgia Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Arthralgia Treatment Sales Market Share by Country/Region (2018-2023)
Table 34. Global Arthralgia Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Arthralgia Treatment Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 37. Americas Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 38. Americas Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 40. Americas Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 41. Americas Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 42. APAC Arthralgia Treatment Sales by Region (2018-2023) & (K Units)
Table 43. APAC Arthralgia Treatment Sales Market Share by Region (2018-2023)
Table 44. APAC Arthralgia Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Arthralgia Treatment Revenue Market Share by Region (2018-2023)
Table 46. APAC Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 47. APAC Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 48. Europe Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 49. Europe Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 50. Europe Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 52. Europe Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 53. Europe Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Arthralgia Treatment Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Arthralgia Treatment Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Arthralgia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Arthralgia Treatment Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Arthralgia Treatment Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Arthralgia Treatment Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Arthralgia Treatment
Table 61. Key Market Challenges & Risks of Arthralgia Treatment
Table 62. Key Industry Trends of Arthralgia Treatment
Table 63. Arthralgia Treatment Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Arthralgia Treatment Distributors List
Table 66. Arthralgia Treatment Customer List
Table 67. Global Arthralgia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Arthralgia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Arthralgia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Arthralgia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Arthralgia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Arthralgia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Arthralgia Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Arthralgia Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Arthralgia Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Arthralgia Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Pfizer Inc. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 82. Pfizer Inc. Arthralgia Treatment Product Portfolios and Specifications
Table 83. Pfizer Inc. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Pfizer Inc. Main Business
Table 85. Pfizer Inc. Latest Developments
Table 86. GSK Plc Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 87. GSK Plc Arthralgia Treatment Product Portfolios and Specifications
Table 88. GSK Plc Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. GSK Plc Main Business
Table 90. GSK Plc Latest Developments
Table 91. Novartis AG Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis AG Arthralgia Treatment Product Portfolios and Specifications
Table 93. Novartis AG Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Novartis AG Main Business
Table 95. Novartis AG Latest Developments
Table 96. Mylan N.V. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 97. Mylan N.V. Arthralgia Treatment Product Portfolios and Specifications
Table 98. Mylan N.V. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Mylan N.V. Main Business
Table 100. Mylan N.V. Latest Developments
Table 101. Teva Pharmaceutical Industries Ltd. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product Portfolios and Specifications
Table 103. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Teva Pharmaceutical Industries Ltd. Main Business
Table 105. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 106. Sanofi S.A Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi S.A Arthralgia Treatment Product Portfolios and Specifications
Table 108. Sanofi S.A Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Sanofi S.A Main Business
Table 110. Sanofi S.A Latest Developments
Table 111. Boehringer Ingelheim International GmbH Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 112. Boehringer Ingelheim International GmbH Arthralgia Treatment Product Portfolios and Specifications
Table 113. Boehringer Ingelheim International GmbH Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Boehringer Ingelheim International GmbH Main Business
Table 115. Boehringer Ingelheim International GmbH Latest Developments
Table 116. AstraZeneca Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Arthralgia Treatment Product Portfolios and Specifications
Table 118. AstraZeneca Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Johnson & Johnson Private Limited Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 122. Johnson & Johnson Private Limited Arthralgia Treatment Product Portfolios and Specifications
Table 123. Johnson & Johnson Private Limited Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Johnson & Johnson Private Limited Main Business
Table 125. Johnson & Johnson Private Limited Latest Developments
Table 126. Merck & Co., Inc. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck & Co., Inc. Arthralgia Treatment Product Portfolios and Specifications
Table 128. Merck & Co., Inc. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Merck & Co., Inc. Main Business
Table 130. Merck & Co., Inc. Latest Developments
Table 131. Hoffmann-La Roche Ltd. Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 132. Hoffmann-La Roche Ltd. Arthralgia Treatment Product Portfolios and Specifications
Table 133. Hoffmann-La Roche Ltd. Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Hoffmann-La Roche Ltd. Main Business
Table 135. Hoffmann-La Roche Ltd. Latest Developments
Table 136. Bristol-Myers Squibb Company Basic Information, Arthralgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 137. Bristol-Myers Squibb Company Arthralgia Treatment Product Portfolios and Specifications
Table 138. Bristol-Myers Squibb Company Arthralgia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Bristol-Myers Squibb Company Main Business
Table 140. Bristol-Myers Squibb Company Latest Developments
List of Figures
Figure 1. Picture of Arthralgia Treatment
Figure 2. Arthralgia Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Arthralgia Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Arthralgia Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Arthralgia Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NSAID
Figure 10. Product Picture of Corticosteroids
Figure 11. Product Picture of Antidepressants
Figure 12. Product Picture of Anticonvulsants
Figure 13. Product Picture of Antibiotics
Figure 14. Global Arthralgia Treatment Sales Market Share by Type in 2022
Figure 15. Global Arthralgia Treatment Revenue Market Share by Type (2018-2023)
Figure 16. Arthralgia Treatment Consumed in Hospital Pharmacy
Figure 17. Global Arthralgia Treatment Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 18. Arthralgia Treatment Consumed in Retail Pharmacy
Figure 19. Global Arthralgia Treatment Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 20. Arthralgia Treatment Consumed in Online Pharmacy
Figure 21. Global Arthralgia Treatment Market: Online Pharmacy (2018-2023) & (K Units)
Figure 22. Global Arthralgia Treatment Sales Market Share by Application (2022)
Figure 23. Global Arthralgia Treatment Revenue Market Share by Application in 2022
Figure 24. Arthralgia Treatment Sales Market by Company in 2022 (K Units)
Figure 25. Global Arthralgia Treatment Sales Market Share by Company in 2022
Figure 26. Arthralgia Treatment Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Arthralgia Treatment Revenue Market Share by Company in 2022
Figure 28. Global Arthralgia Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Arthralgia Treatment Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 31. Americas Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 32. APAC Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 33. APAC Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Europe Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 35. Europe Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Arthralgia Treatment Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Arthralgia Treatment Revenue 2018-2023 ($ Millions)
Figure 38. Americas Arthralgia Treatment Sales Market Share by Country in 2022
Figure 39. Americas Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 40. Americas Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 41. Americas Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 42. United States Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Arthralgia Treatment Sales Market Share by Region in 2022
Figure 47. APAC Arthralgia Treatment Revenue Market Share by Regions in 2022
Figure 48. APAC Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 49. APAC Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 50. China Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Arthralgia Treatment Sales Market Share by Country in 2022
Figure 58. Europe Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 59. Europe Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 60. Europe Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 61. Germany Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Arthralgia Treatment Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Arthralgia Treatment Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Arthralgia Treatment Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Arthralgia Treatment Sales Market Share by Application (2018-2023)
Figure 70. Egypt Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Arthralgia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Arthralgia Treatment in 2022
Figure 76. Manufacturing Process Analysis of Arthralgia Treatment
Figure 77. Industry Chain Structure of Arthralgia Treatment
Figure 78. Channels of Distribution
Figure 79. Global Arthralgia Treatment Sales Market Forecast by Region (2024-2029)
Figure 80. Global Arthralgia Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Arthralgia Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Arthralgia Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Arthralgia Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Arthralgia Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の関節痛治療市場予測 2023年-2029年] (コード：LP23DC00657)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の関節痛治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の関節痛治療市場予測 2023年-2029年
  • 世界の筋骨格系腫瘍治療市場予測 2023年-2029年
  • 世界の前立腺肥大症治療装置市場予測 2023年-2029年
  • 世界の膜性腎症治療市場予測 2023年-2029年
  • 世界のアルコール使用障害用治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆